Tran TA - Search Results

1

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

Ahlgren S, Wållberg H, Tran TA, Widström C, Hjertman M, Abrahmsén L, Berndorff D, Dinkelborg LM, Cyr JE, Feldwisch J, Orlova A, Tolmachev V. Ahlgren S, et al. Among authors: tran ta. J Nucl Med. 2009 May;50(5):781-9. doi: 10.2967/jnumed.108.056929. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372467 Free article.

2

Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence.

Engfeldt T, Orlova A, Tran T, Bruskin A, Widström C, Karlström AE, Tolmachev V. Engfeldt T, et al. Eur J Nucl Med Mol Imaging. 2007 May;34(5):722-733. doi: 10.1007/s00259-006-0266-4. Epub 2006 Dec 5. Eur J Nucl Med Mol Imaging. 2007. PMID: 17146656

3

Comparison of benzoate- and dodecaborate-based linkers for attachment of radioiodine to HER2-targeting Affibody ligand.

Tran T, Orlova A, Sivaev I, Sandström M, Tolmachev V. Tran T, et al. Int J Mol Med. 2007 Mar;19(3):485-93. Int J Mol Med. 2007. PMID: 17273798

4

In vivo evaluation of cysteine-based chelators for attachment of 99mTc to tumor-targeting Affibody molecules.

Tran T, Engfeldt T, Orlova A, Widström C, Bruskin A, Tolmachev V, Karlström AE. Tran T, et al. Bioconjug Chem. 2007 Mar-Apr;18(2):549-58. doi: 10.1021/bc060291m. Epub 2007 Mar 2. Bioconjug Chem. 2007. PMID: 17330952

5

Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.

Orlova A, Tolmachev V, Pehrson R, Lindborg M, Tran T, Sandström M, Nilsson FY, Wennborg A, Abrahmsén L, Feldwisch J. Orlova A, et al. Cancer Res. 2007 Mar 1;67(5):2178-86. doi: 10.1158/0008-5472.CAN-06-2887. Cancer Res. 2007. PMID: 17332348

6

99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.

Engfeldt T, Tran T, Orlova A, Widström C, Feldwisch J, Abrahmsen L, Wennborg A, Karlström AE, Tolmachev V. Engfeldt T, et al. Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1843-53. doi: 10.1007/s00259-007-0474-6. Epub 2007 Jun 13. Eur J Nucl Med Mol Imaging. 2007. PMID: 17565496

7

Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.

Orlova A, Tran T, Widström C, Engfeldt T, Eriksson Karlström A, Tolmachev V. Orlova A, et al. Int J Mol Med. 2007 Sep;20(3):397-404. Int J Mol Med. 2007. PMID: 17671747

8

(99m)Tc-maEEE-Z(HER2:342), an Affibody molecule-based tracer for the detection of HER2 expression in malignant tumors.

Tran T, Engfeldt T, Orlova A, Sandström M, Feldwisch J, Abrahmsén L, Wennborg A, Tolmachev V, Karlström AE. Tran T, et al. Bioconjug Chem. 2007 Nov-Dec;18(6):1956-64. doi: 10.1021/bc7002617. Epub 2007 Oct 19. Bioconjug Chem. 2007. PMID: 17944527

9

Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake.

Ekblad T, Tran T, Orlova A, Widström C, Feldwisch J, Abrahmsén L, Wennborg A, Karlström AE, Tolmachev V. Ekblad T, et al. Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2245-55. doi: 10.1007/s00259-008-0845-7. Epub 2008 Jul 2. Eur J Nucl Med Mol Imaging. 2008. PMID: 18594815

10

Effects of lysine-containing mercaptoacetyl-based chelators on the biodistribution of 99mTc-labeled anti-HER2 Affibody molecules.

Tran TA, Ekblad T, Orlova A, Sandström M, Feldwisch J, Wennborg A, Abrahmsén L, Tolmachev V, Eriksson Karlström A. Tran TA, et al. Bioconjug Chem. 2008 Dec;19(12):2568-76. doi: 10.1021/bc800244b. Bioconjug Chem. 2008. PMID: 19035668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters